COMMUNIQUÉS West-GlobeNewswire

DiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
13/08/2019
Phase Ib study of DM199 in Chronic Kidney Disease enrollment complete Encouraging early signals in mechanism biomarkers (NO and PGE2), Kidney function (eGFR) and urine albumin (UACR) Phase II CKD protocol submitted, [...]
Novan Takes Steps to Reduce Real Estate Footprint
13/08/2019
Company entered into negotiations with third party to transfer lease obligation Non-binding letter of intent signed 60-day exclusivity period to finalize details A successful transaction would lead to a reduction in [...]
Aeterna Zentaris Reports Second Quarter 2019 Financial and Operating Results
13/08/2019
CHARLESTON, S.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) today reported its financial and operating results for the second quarter ended June 30, 2019. All Amounts are in U.S [...]
Altimmune Announces Second Quarter 2019 Financial Results and Provides a Business Update
13/08/2019
Conference Call & Webcast Scheduled for Wednesday, August 14, at 8:30am Eastern Time GAITHERSBURG, Md., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, [...]
Crinetics Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
13/08/2019
SAN DIEGO, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Acer Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
13/08/2019
NEWTON, Mass., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life- [...]
Cyclacel Pharmaceuticals Reports Second Quarter 2019 Financial Results
13/08/2019
- Conference Call Scheduled August 13, 2019 at 4:30 p.m. ET – BERKELEY HEIGHTS, N.J., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a [...]
Silk Road Medical Announces Closing of Follow-on Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
13/08/2019
SUNNYVALE, Calif., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, today announced the closing [...]
CorMedix Inc. Reports Second Quarter and Six Month 2019 Financial Results and Provides Business Update
13/08/2019
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time BERKELEY HEIGHTS, N.J., Aug. 13, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and [...]
Adaptive Biotechnologies Corporation Reports Second Quarter 2019 Financial Results
13/08/2019
SEATTLE, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT) today reported financial results for the quarter ended June 30, 2019. “At Adaptive, we are [...]
electroCore Announces Second Quarter 2019 Financial Results
13/08/2019
Sequential growth reported in paid months of therapy, prescribing physicians and prescriptions dispensed Company to host conference call and webcast today, August 13, at 4:30pm ET BASKING RIDGE, N.J., Aug. 13, 2019 ( [...]
Shlomo Yanai Resigns as Chairman of the Board of Protalix BioTherapeutics
13/08/2019
CARMIEL, Israel, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX) today announced that Shlomo Yanai has resigned from the Company’s Board of Directors for personal reasons [...]
Atreca Reports Second Quarter 2019 Financial Results and Recent Corporate Developments
13/08/2019
REDWOOD CITY, Calif., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, [...]
Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2019 Financial Results
13/08/2019
Total Fourth-Quarter Revenues of $215.4 Million Fourth-Quarter Diluted EPS of ($0.06) and Adjusted EPS of $0.41 SALT LAKE CITY, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “ [...]
Forty Seven Inc. Reports Second Quarter 2019 Financial Results and Recent Business Highlights
13/08/2019
-- Presented Updated Data for 5F9 in Four Patient Populations at ASCO and EHA Meetings -- -- Received FDA Feedback Suggesting Single-Arm Pivotal Trials May Support Registration in MDS and DLBCL -- -- Entered Exclusive [...]
PhaseBio Reports Second Quarter 2019 Financial Results and Recent Corporate Progress
13/08/2019
Reported positive preliminary results from Phase 2a trial of PB2452 Received FDA Breakthrough Therapy designation for PB2452 Completed underwritten public offering of common stock that raised $46.3 million in net [...]
Itchy Scalp? How to Find Head Lice Early; American Academy of Dermatology
13/08/2019
Ahead of the new school year, dermatologists encourage parents to be on the lookout for these pesky critters ROSEMONT, Ill., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Head lice affect about six to 12 million children, ages [...]
Endonovo Therapeutics Announces Second Quarter Results
13/08/2019
LOS ANGELES, Aug. 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Endonovo Therapeutics, Inc . (OTCQB: ENDV) ("Endonovo" or the "Company"), today announces financial and operating results for the second quarter ended [...]
CROSSJECT : Descriptif du programme de rachat d'actions
13/08/2019
Communiqué de Presse Descriptif du programme de rachat d’actions 2019-2020 Dijon, le 13 août 2019 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un [...]

Pages